載入...
Cardio-toxicity of checkpoint inhibitors
Immune checkpoint inhibitors (ICIs) have started revolutionizing the treatment of numerous advanced oncological diseases by restoring immune resistance against cancer cells. ICI-associated cardiac adverse effects are rare, but severe. About 50% of cardiac complications comprise myocarditis with vari...
Na minha lista:
| 發表在: | J Thorac Dis |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6328389/ https://ncbi.nlm.nih.gov/pubmed/30701107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.12.78 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|